Bindu Bennet

595 total citations
12 papers, 126 citations indexed

About

Bindu Bennet is a scholar working on Small Animals, Immunology and Cancer Research. According to data from OpenAlex, Bindu Bennet has authored 12 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Small Animals, 8 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Bindu Bennet's work include Immunotoxicology and immune responses (8 papers), Animal testing and alternatives (8 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Bindu Bennet is often cited by papers focused on Immunotoxicology and immune responses (8 papers), Animal testing and alternatives (8 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Bindu Bennet collaborates with scholars based in United States, Switzerland and France. Bindu Bennet's co-authors include Rani S. Sellers, Jayanthi Wolf, Brad Bolon, Ferid Murad, L. D. Hayward, Niraj Tripathi, Aaron M. Sargeant, Sundeep Chandra, Joan H. Lane and David Hutto and has published in prestigious journals such as Mutation Research/Genetic Toxicology and Environmental Mutagenesis and Toxicologic Pathology.

In The Last Decade

Bindu Bennet

10 papers receiving 121 citations

Peers

Countries citing papers authored by Bindu Bennet

Since Specialization

Citations

This map shows the geographic impact of Bindu Bennet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bindu Bennet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bindu Bennet more than expected).

Fields of papers citing papers by Bindu Bennet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bindu Bennet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bindu Bennet. The network helps show where Bindu Bennet may publish in the future.

Co-authorship network of co-authors of Bindu Bennet

This figure shows the co-authorship network connecting the top 25 collaborators of Bindu Bennet. A scholar is included among the top collaborators of Bindu Bennet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bindu Bennet. Bindu Bennet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Scientific and Regulatory Policy Committee Points to Consider: Review of the United States Food and Drug Administration (FDA) Guidance on Pathology Peer Review in Nonclinical Toxicology Studies 2024 ·Toxicologic Pathology ·Kevin S. McDorman, Bindu Bennet, Karyn Colman, James Fikes, Natalie Keirstead, Lynda Lanning, (unknown), (unknown), Kenneth A. Schafer, Frédéric Schorsch, Michael S. Thibodeau, Heath C. Thomas, Sean P. Troth, John L. Vahle, Frank J. Geoly	0
2	Scientific and Regulatory Policy Committee Technical Review: Biology and Pathology of Ganglia in Animal Species Used for Nonclinical Safety Testing 2023 ·Toxicologic Pathology ·Bindu Bennet, Ingrid D. Pardo, Basel T. Assaf, Elizabeth L. Buza, Sarah D. Cramer, LaTasha K. Crawford, (unknown), Elizabeth J. Galbreath, Branka Grubor, James P. Morrison, Tanasa S. Osborne, Alok Sharma, Brad Bolon	5
3	Scientific and Regulatory Policy Committee Points to Consider: Sampling, Processing, Evaluation, Interpretation, and Reporting of Test Article-Related Ganglion Pathology for Nonclinical Toxicity Studies 2023 ·Toxicologic Pathology ·Bindu Bennet, Ingrid D. Pardo, Basel T. Assaf, Elizabeth L. Buza, Sarah D. Cramer, LaTasha K. Crawford, Jeffery A. Engelhardt, Branka Grubor, James P. Morrison, Tanasa S. Osborne, Alok Sharma, Brad Bolon	7
4	Toxicologic Pathology Forum: Opinion on Not Euthanizing Control Animals in the Recovery Phase of Non-Rodent Toxicology Studies 2022 ·Toxicologic Pathology ·Kyathanahalli S. Janardhan, Radhakrishna Sura, (unknown), Thierry Flandre, Xavier Palazzi, (unknown), Bhanu Singh, (unknown), Renee Hukkanen, (unknown), Bindu Bennet, (unknown), (unknown), Richard A. Peterson, (unknown), Frédéric Schorsch, Magali Guffroy	2
5	Scientific and Regulatory Policy Committee Points to Consider: Biological Sample Retention From Nonclinical Toxicity Studies 2021 ·Toxicologic Pathology ·Carole E. Harbison, (unknown), Bindu Bennet, (unknown), Mary Carsillo, (unknown), Natalie Keirstead, Krista M. D. La Perle, Arun R. Pandiri, Ahmed Shoieb, (unknown)	0
6	Scientific and Regulatory Policy Committee Points to Consider: Fixation, Trimming, and Sectioning of Nonrodent Eyes and Ocular Tissues for Examination in Ocular and General Toxicity Studies 2021 ·Toxicologic Pathology ·Helen Booler, (unknown), Steven D. Sorden, (unknown), Kenneth A. Schafer, Brian Short, Cindy Farman, Meg Ferrell Ramos, Bindu Bennet, (unknown), (unknown), Oliver C. Turner, Jacqueline Brassard, George L. Foley	6
7	Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19) 2020 ·Toxicologic Pathology ·Bindu Bennet, Jayanthi Wolf, (unknown), Rani S. Sellers	30
8	Scientific Regulatory Policy Committee Points to Consider: Nuisance Factors, Block Effects, and Batch Effects in Nonclinical Safety Assessment Studies 2020 ·Toxicologic Pathology* ·A. Eric Schultze, Bindu Bennet, (unknown), Alan Y. Chiang, Kendall S. Frazier, Paula Katavolos, (unknown), Daniel J. Patrick, Niraj Tripathi	5
9	Scientific and Regulatory Policy Committee Points to Consider: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists 2019 ·Toxicologic Pathology* ·Rani S. Sellers, Keith Nelson, Bindu Bennet, Jayanthi Wolf, Niraj Tripathi, Ronnie Chamanza, (unknown), Karissa Adkins, Sébastien Laurent, Sean P. Troth	14
10	Scientific and Regulatory Policy Committee Points to Consider: Histopathologic Evaluation in Safety Assessment Studies for PEGylated Pharmaceutical Products 2018 ·Toxicologic Pathology ·(unknown), Bindu Bennet, Brad Bolon, (unknown), Sundeep Chandra, (unknown), Robert H. Garman, David Hutto, Joan H. Lane, (unknown), Aaron M. Sargeant, (unknown)	29
11	Alkaline comet assay in liver and stomach, and micronucleus assay in bone marrow, from rats treated with 2-acetylaminofluorene, azidothymidine, cisplatin, or isobutyraldehyde 2015 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Andrew R. Kraynak, John E. Barnum, Christopher L. Cunningham, Andrea K. Ng, (unknown), Bindu Bennet, (unknown), (unknown), (unknown), Sheila M. Galloway	14
12	Cultured rat lung fibroblasts as a model for organic nitrate-induced cyclic GMP accumulation and activation of guanylate cyclase 1987 ·(unknown), (unknown), L. D. Hayward, Bindu Bennet, Ferid Murad	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact